INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Clinical trial NCT03838042 · RECRUITING
Trial details
- NCT number
- NCT03838042
- Sponsor
- University Hospital Heidelberg
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2026-06-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.